Parenteral Nutrition Market to 2018 – Rising Incidence of Chronic Diseases such as Cancer, AIDS and Gastrointestinal (GI) Disorders, and Increased Use of Specialty Drugs Drive Growth

Publisher Name :
Date: 9-Nov-2012
No. of pages: 70

GBI Research, the leading business intelligence provider, has released its latest research, “Parenteral Nutrition Market to 2018 Rising Incidence of Chronic Diseases such as Cancer, AIDS and Gastrointestinal (GI) Disorders, and Increased Use of Specialty Drugs Drive Growth”. It provides in-depth analysis of the market size and drivers and barriers that affect the PN market. The report analyzes the markets for parenteral nutrition in the US, the top five countries in Europe (the UK, Germany, France, Italy and Spain) and Japan. Sales value is forecast until 2018 for key geographies. Further, the report provides competitive benchmarking for the leading companies and analyzes the mergers and acquisitions (M&A) and licensing agreements that shape the global markets.

The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Research’s team of industry experts.

The PN market is rapidly growing with the increasing incidence of diseases such as cancer, AIDS and GI disorders including short bowel syndrome, ischemic bowel disease, pseudo obstruction and Crohn’s disease. The other major factor driving growth of the PN market is an increase in the elderly population in the developed countries. In 2011, the global PN market was estimated to be worth $2.9 billion, representing a CAGR of 6.3% between 2004 and 2011. The US market, with sales worth $1,476m in 2011, accounted for 50.7% of the total PN market. The market in the top five countries in Europe was estimated to be $1,275m, the second largest PN market, and to have grown at a CAGR of 5.4% between 2004 and 2011. The PN market in Japan registered a share of 5.4% of the total PN market, accounting for $157m sales value in 2011.

By 2018, the PN market is forecast to be worth $4,861m, representing a CAGR of 7.6% between 2011 and 2018. The US is expected to remain the largest segment in the PN market with $2,492m of sales in 2018. The PN market in the top five countries in Europe will be the second largest segment with $2,104m in revenues in 2018. Japan, which was the smallest segment in 2011, is expected to register sales value of $265m in 2018, indicating a CAGR of 7.8% between 2011 and 2018. The PN market M&A landscape demonstrated a fairly moderate level of activity between 2004 and 2010, with seven major acquisition deals signed during the time period.

Scope

  • Annualized market data for the PN market from 2004 to 2011, forecast forward to 2018.
  • Analysis of the PN market in the leading geographies of the world, which include the US, the top five countries in Europe (the UK, Germany, France, Italy, Spain) and Japan.
  • Market segmentation of the PN market which includes the amino acid, lipids, carbohydrates and additives market in the leading geographies.
  • Key drivers and barriers that have a significant impact on the market.
  • Competitive benchmarking of the leading companies. The key companies studied in this report are Baxter, B. Braun, Fresenius Kabi, Hospira, Otsuka Pharmaceutical Factory, Terumo Corporation and Ajinomoto.
  • Key M&A activities, licensing agreements that have taken place between 2004 and 2011 in the global PN market.

Reasons to buy

  • Develop market-entry and market expansion strategies by identifying the leading geographic markets poised for strong growth.
  • Reinforce R&D pipelines by identifying new target mechanisms which can produce first-in-class products with more efficiency and better safety.
  • Develop key strategic initiatives by understanding the key focus areas of leading companies.
  • Exploit in-licensing and out-licensing opportunities by identifying products that could fill portfolio gaps.

Parenteral Nutrition Market to 2018 – Rising Incidence of Chronic Diseases such as Cancer, AIDS and Gastrointestinal (GI) Disorders, and Increased Use of Specialty Drugs Drive Growth

Table of Contents

1 Table of Contents 5
1.1 List of Tables 7
1.2 List of Figures 8

2 Parenteral Nutrition Market to 2018 - Introduction 9

3 Parenteral Nutrition Market to 2018 - Overview 10

3.1 Clinical Nutrition 10
3.1.1 Enteral Nutrition 11
3.1.2 Parenteral Nutrition 11

4 Parenteral Nutrition Market to 2018 - Market Characterization and Forecasts 15
4.1 Revenue Forecasts 15
4.2 Parenteral Nutrition Market Drivers 16
4.2.1 Increase in the Incidence of Diseases such as Cancer, AIDS and GI Disorders that Require Nutrition Support 17
4.2.2 Increase in the Elderly Population will Drive PN Market Growth 17
4.2.3 The Home Parenteral Nutrition Sector will Witness Strong Market Growth 17
4.3 Parenteral Nutrition Market Restraints 17
4.3.1 Reimbursement Regulations will Hinder Market Growth in the US 17
4.3.2 Increasing Preference for Enteral Nutrition will Restrain Market Growth 17
4.3.3 Increasing Preference for Multi-chamber Bags Decreases Cost of Therapy 18

5 Parenteral Nutrition Market to 2018 - Geographical Landscape 19
5.1 Revenues by Geographical Segmentation 19
5.2 The US 21
5.2.1 Sales Value 21
5.2.2 Nutrient Market Segmentation 22
5.2.3 Key Products 22
5.3 Top Five Countries in Europe 23
5.3.1 Sales Value 23
5.3.2 Nutrient Market Segmentation 24
5.3.3 Key Products 24
5.4 Japan 25
5.4.1 Sales Value 25
5.4.2 Nutrient Market Segmentation 26
5.4.3 Key Products 26

6 Parenteral Nutrition Market to 2018 - Nutrient Market Segmentation 27
6.1 Overview 27
6.2 Amino Acids Market 28
6.2.1 Global Sales Value 28
6.2.2 Sales Value by Geography 28
6.3 Lipids Market 29
6.3.1 Global Sales Value 29
6.3.2 Sales Value by Geography 29
6.4 Carbohydrates Market 30
6.4.1 Global Sales Value 30
6.4.2 Sales Value by Geography 30
6.5 Additives Market 31
6.5.1 Global Sales Value 31
6.5.2 Sales Value by Geography 31

7 Parenteral Nutrition Market - Marketed Products 32
7.1 Baxter International Inc. 32
7.1.1 OLIMEL 32
7.1.2 Clinimix 33
7.1.3 ClinOleic 20% 34
7.1.4 Clinisol 15% 35
7.2 B. Braun Melsungen AG 36
7.2.1 NuTRIflex System 36
7.2.2 Lipofundin 37
7.2.3 Aminoplasmal 38
7.2.4 FreAmine III 39
7.3 Fresenius Kabi AG 40
7.3.1 Intralipid 40
7.3.2 SmofKabiven 41
7.3.3 Dipeptiven 42
7.3.4 Omegaven 43
7.4 Hospira, Inc. 44
7.4.1 Aminosyn 44
7.4.2 Liposyn 46
7.5 Otsuka Pharmaceutical Factory Inc. 47
7.5.1 Elneopa 47
7.5.2 Neoparen 47
7.5.3 B-Fluid 48
7.6 Terumo Corporation 49
7.6.1 Unicaliq 49
7.6.2 Fulcaliq 50

8 Parenteral Nutrition Market to 2018 - Competitive Landscape 51
8.1 Market Share Analysis: Parenteral Nutrition 51
8.2 Competitive Profiling 52
8.2.1 Baxter International Inc. 52
8.2.2 B. Braun Melsungen AG 54
8.2.3 Fresenius Kabi AG 56
8.2.4 Hospira, Inc. 58
8.2.5 Otsuka Pharmaceutical Factory Inc. 60
8.2.6 Terumo Corporation 61

9 Parenteral Nutrition Market to 2018 - Strategic Consolidations 62
9.1 Overview 62
9.2 Major Acquisitions in the Parenteral Nutrition Market 63
9.2.1 Baxter International Completes Acquisition of Prism Pharma for $338m in April 2011 63
9.2.2 Baxter Acquires Willow Healthcare Services in July 2009 63
9.2.3 Fresenius Acquires Novartis Nutrition and Nestle Espana in December 2007 63
9.2.4 Fresenius Kabi Acquires Infusia A.S. in December 2004 63
9.2.5 Fresenius Kabi Acquires Clinico GmbH in October 2005 63
9.2.6 Fresenius Kabi Acquires Isotec Nutrition from Alliance Pharmaceuticals in May 2004 63
9.2.7 Hospira Acquires Clayton Manufacturing Facility from Fresenius Kabi in June 2004 63
9.3 Major Agreements in the Parenteral Nutrition Market 64
9.3.1 Baxter Signs Agreement with Hanmi Pharmaceuticals in December 2010 64
9.3.2 Hospira Signs a Five-year Agreement with Novation in October 2010 64
9.3.3 B. Braun Signs Agreement with Amerinet Inc in October 2009 64
9.3.4 B. Braun Signs Agreement with Premier Purchasing Partners in August 2008 64
9.3.5 Hospira Announces New Contract with Premier Purchasing Partners in August 2008 65
9.3.6 Hospira Announces New Contract with HealthTrust Purchasing Group in February 2008 65
9.3.7 Baxter and Novation Sign Two-year Contract Extension in October 2007 65
9.3.8 Baxter Announces Plans to Form Parenteral Nutrition Joint Venture with Baiyunshan in China in August 2007 65
9.3.9 B. Braun Signs Agreement with Curlin Medical in March 2006 65
9.3.10 Fresenius Kabi and Pharmatel Pty Ltd. Formed a Joint Venture in September 2004 66

10 Parenteral Nutrition Market to 2018 - Appendix 67
10.1 Market Definitions 67
10.2 Abbreviations 67
10.3 Bibliography 68
10.4 Research Methodology 69
10.4.1 Coverage 69
10.4.2 Secondary Research 69
10.4.3 Primary Research 69
10.4.4 Section Methodology 70
10.4.5 Expert Panel Validation 70
10.5 Contact Us 70
10.6 Disclaimer 70

List of Tables

Table 1: Parenteral Nutrition Market, Global, Nutritional Status Assessment, 2011 10
Table 2: Parenteral Nutrition Market, The US, A.S.P.E.N. Guidelines for Parenteral Nutrition, 2004 13
Table 3: Parenteral Nutrition Market, Global, Revenues ($m), 2004-2011 15
Table 4: Parenteral Nutrition Market, Global, Revenue Forecasts ($m), 2011-2018 15
Table 5: Parenteral Nutrition Market, Global, Revenue by Geographical Segmentation ($m), 2004-2011 19
Table 6: Parenteral Nutrition Market, Global, Revenue Forecasts by Geographical Segmentation ($m), 2011-2018 20
Table 7: Parenteral Nutrition Market, The US, Revenues ($m), 2004-2011 21
Table 8: Parenteral Nutrition Market, The US, Revenue Forecasts ($m), 2011-2018 21
Table 9: Parenteral Nutrition Market, Top Five Countries of Europe, Revenues ($m), 2004-2011 23
Table 10: Parenteral Nutrition Market, Top Five Countries of Europe, Revenue Forecasts ($m), 2011-2018 23
Table 11: Parenteral Nutrition Market, Japan, Revenues ($m), 2004-2011 25
Table 12: Parenteral Nutrition Market, Japan, Revenue Forecasts ($m), 2011-2018 25
Table 13: Parenteral Nutrition Market, Amino Acids Revenue by Geographical Segmentation ($m), 2011 28
Table 14: Parenteral Nutrition Market, Lipids Revenue by Geographical Segmentation ($m), 2011 29
Table 15: Parenteral Nutrition Market, Carbohydrates Revenue by Geographical Segmentation ($m), 2011 30
Table 16: Parenteral Nutrition Market, Additives Revenue by Geographical Segmentation ($m), 2011 31
Table 17: Parenteral Nutrition Market, Global, Product Composition - Lipofundin, 2012 37
Table 18: Parenteral Nutrition Market, Global, Product Composition - Aminoplasmal, 2012 38
Table 19: Parenteral Nutrition Market, Global, Product Composition - Aminosyn, 2012 45
Table 20: Parenteral Nutrition Market, Global, Strategic Consolidations Overview, 2012 62

List of Figures

Figure 1: Parenteral Nutrition Market, Global, Nutritional Support Algorithm 11
Figure 2: Parenteral Nutrition Market, Global, Nutrition Requirements for TPN, 2012 12
Figure 3: Parenteral Nutrition Market, Global, Revenues ($m), 2004-2018 15
Figure 4: Parenteral Nutrition Market, Global, Drivers and Barriers, 2012 16
Figure 5: Parenteral Nutrition Market, Global, Revenue by Geographical Segmentation ($m), 2004-2018 19
Figure 6: Parenteral Nutrition Market, The US, Historic Revenue and Forecasts ($m), 2004-2018 21
Figure 7: Parenteral Nutrition Market, The US, Key Products, 2012 22
Figure 8: Parenteral Nutrition Market, Top Five Countries of Europe, Historic Revenue and Forecasts ($m), 2004-2018 23
Figure 9: Parenteral Nutrition Market, Top Five Countries in Europe, Key Products, 2011 24
Figure 10: Parenteral Nutrition Market, Japan, Revenue Forecasts ($m), 2004-2018 25
Figure 11: Parenteral Nutrition Market, Japan, Key Products, 2011 26
Figure 12: Parenteral Nutrition Market, Global, Nutrient Market Segmentation (%), 2011 27
Figure 13: Parenteral Nutrition Market, Amino Acids Revenue by Geographical Segmentation ($m), 2011 28
Figure 14: Parenteral Nutrition Market, Lipids Revenue by Geographical Segmentation ($m), 2011 29
Figure 15: Parenteral Nutrition Market, Carbohydrates Revenue by Geographical Segmentation ($m), 2011 30
Figure 16: Parenteral Nutrition Market, Additives Revenue by Geographical Segmentation ($m), 2011 31
Figure 17: Parenteral Nutrition Market, Global, Product Profile - OLIMEL, 2012 32
Figure 18: Parenteral Nutrition Market, Global, Product Profile - Clinimix, 2012 33
Figure 19: Parenteral Nutrition Market, Global, Product Profile - ClinOleic 20%, 2012 34
Figure 20: Parenteral Nutrition Market, Global, Product Profile - Clinisol 15%, 2012 35
Figure 21: Parenteral Nutrition Market, Global, Product Profile - NuTRIflex, 2012 36
Figure 22: Parenteral Nutrition Market, Global, Product Profile - Lipofundin, 2012 37
Figure 23: Parenteral Nutrition Market, Global, Product Profile - Aminoplasmal, 2012 38
Figure 24: Parenteral Nutrition Market, Global, Product Profile - FreAmine III, 2012 39
Figure 25: Parenteral Nutrition Market, Global, Product Profile-Intralipid, 2012 40
Figure 26: Parenteral Nutrition Market, Global, Product Profile - SmofKabiven, 2012 41
Figure 27: Parenteral Nutrition Market, Global, Product Profile - Dipeptiven, 2012 42
Figure 28: Parenteral Nutrition Market, Global, Product Profile - Omegaven, 2012 43
Figure 29: Parenteral Nutrition Market, Global, Product Profile - Aminosyn, 2012 44
Figure 30: Parenteral Nutrition Market, Global, Product Profile - Liposyn, 2012 46
Figure 31: Parenteral Nutrition Market, Global, Product Profile - Neoparen, 2012 47
Figure 32: Parenteral Nutrition Market, Global, Product Profile - B-Fluid, 2012 48
Figure 33: Parenteral Nutrition Market, Global, Product Profile - Unicaliq, 2012 49
Figure 34: Parenteral Nutrition Market, Global, Product Profile - Fulcaliq, 2012 50
Figure 35: Parenteral Nutrition Market, Global, Market Share of Top Manufacturers (%), 2011 51
Figure 36: Parenteral Nutrition Market to 2018, Global, Company Profile - Baxter International Inc., 2012 52
Figure 37: Parenteral Nutrition Market, Global, SWOT Analysis - Baxter International Inc., 2012 53
Figure 38: Parenteral Nutrition Market to 2018, Global, Company Profile - B. Braun Melsungen AG, 2012 54
Figure 39: Parenteral Nutrition Market, Global, SWOT Analysis - B. Braun Melsungen AG, 2012 55
Figure 40: Parenteral Nutrition Market, Global, Company Profile - Fresenius Kabi AG, 2012 56
Figure 41: Parenteral Nutrition Market, Global, SWOT Analysis - Fresenius Kabi AG, 2012 57
Figure 42: Parenteral Nutrition Market, Global, Company Profile - Hospira Inc., 2012 58
Figure 43: Parenteral Nutrition Market, Global, SWOT Analysis - Hospira Inc., 2012 59
Figure 44: Parenteral Nutrition Market, Global, Company Profile - Otsuka Pharmaceutical Factory Inc., 2012 60
Figure 45: Parenteral Nutrition Market, Global, Company Profile - Terumo Corporation, 2012 61
Figure 46: Parenteral Nutrition Market, Global, Strategic Consolidations Overview (%), 2012 62

  • Challenges in the Tourism Industry in Thailand
    Thailand has always been a popular tourist destination and tourism provides a major boost to the country’s economy. Bangkok, Hua Hin, Krabi, Samui, Phuket and Cha Am are some of the most attractive tourist destinations in the country. In 2012, Thailand had a very high number of arrivals. Even the number of Thai citizens who [...]
  • Future of the US Consumer Electronics Market
    The market for consumer electronics has been growing steadily. Some of the factors that are contributing to the growth in the market are technological advancement, rise in disposable income and increasing demand for new products. During 2012, consumer electronics market in the US demonstrated positive expansion, although the growth rate slowed down considerably following the [...]
  • Overview of the Global Retail Market
    The global retail industry continued to grow despite the difficult economic conditions in the world. In the fiscal year of 2011, sales-weighted, currency-adjusted revenue rose by 5.1% to $4.271 trillion for the world’s top 250 retailers. According to GRDI (Global Retail Development Index), in 2013 Brazil occupied the top spot in retail development. Chile and [...]
  • Bright Future Predicted for the Tourism Industry in Singapore
    Travel and tourism industry in Singapore has been growing at a steady rate and is considered to be a major contributor to the economic growth of the country. In 2012, Singapore’s IVA (International Visitors Arrivals) reached a record high of 14.5 million, with a growth rate of 10.1% year-on-year. In recent years, inbound travel to [...]
  • Potential of Staffing Market in United States
    The staffing industry places individuals into contract, temporary and permanent positions in firms around the world. Major staffing markets include France, Spain, Italy and Japan as well as many emerging markets. Temporary staffing around the world has been growing, but in US temporary market has been flat since 2006. The majority of staffing revenue majorly [...]
  • Graft-Versus-Host Disease (GVHD) Treatment Market worth $407 million by 2018
  • The graft-versus-host disease (GVHD) treatment market value will increase from $297 million in 2013 to $407 million by 2018, at a Compound Annual Growth Rate (CAGR) of 6.59%, according to research and consulting firm GlobalData. The company’s latest report* states …

  • Poland Pharmaceutical Industry Growing at 8.3% CAGR to 2020
  • Factors such as the growing elderly population, increasing availability of affordable medicines, and transparent regulatory guidelines will provide the necessary impetus for the growth of the Polish pharmaceutical market, but a decrease in mark-up prices and the country’s stringent drug …

  • Asia-Pacific, Led by China, Drive the Global Methanol Industry
  • China is driving the global methanol industry, with tremendous demand from both its energy and petrochemicals sectors. It accounts for 87.9% of Asia-Pacific’s (APAC) methanol capacity, and 51.9% of the global methanol capacity. Despite a large planned capacity increase in …

  • Diagnostic X-ray Imaging Market worth $4.0 billion by 2020
  • GlobalData estimates that the global diagnostic X-ray imaging market, worth $2.4 billion in 2012, will reach almost $4.0 billion by 2020, increasing at a Compound Annual Growth Rate (CAGR) of 6.7% during the forecast period. Many players are active in …

  • Graft-Versus-Host Disease Market Forecast to 2023
  • Graft-versus-host disease (GVHD) is a common complication of allogeneic hematopoietic stem cell transplantation (HSCT) that occurs when the donated (graft) cells are rejected and attack the host’s cells as foreign. GVHD can progress from mild to severe forms as either …

  • Identifying and Commercializing First-in-Class Innovation in Non-Small-Cell Lung Carcinoma
    Published: 29-Oct-2014        Price: US $6995 Onwards        
    Large Degree of Innovation in NSCLC Pipeline The NSCLC pipeline currently has 389 products in active development across all stages, but a stark contrast between the mechanisms of action employed in the current market and the pipeline is evident. Where the market comprises primarily ineffective chemotherapies that target tubulin or DNA replication, the pipeline shows an incredibly diverse range of therapies targeting multiple signaling pathways and molecules integral to cancer development. Thi......
  • Global Biologic Therapeutics Market 2014-2018
    Published: 29-Oct-2014        Price: US $3500 Onwards        Pages: 185
    Biologic therapeutics include virus, therapeutic serum, toxin, allergenic product, antitoxin, blood component or derivative, vaccine, blood, protein (except any chemically synthesized polypeptide), or analogous product, or arsphenamine or derivative of arsphenamine (or any other trivalent organic arsenic compound), intended for the prevention, treatment, or cure of a disease or condition. These products differ from small molecules in terms of molecular weight, structure, synthesis, and immunogen......
  • Global Pharmaceutical Packaging Market 2014-2018
    Published: 29-Oct-2014        Price: US $2500 Onwards        Pages: 77
    A pharmaceutical product is any chemical substance formulated or compounded as a single active ingredient. The packaging of medicines is a very complex process, and because of its molecular and chemical structure, it needs to be packed in an extremely durable material so that it could reach the customer in a desirable condition. The evolution of new diseases and increased health awareness have brought a transformation in the Pharmaceutical Packaging market. The vendors in the Global Pharmaceutic......
  • 2014 Deep Research Report on Global and China Nalbuphine HCL Industry
    Published: 28-Oct-2014        Price: US $2200 Onwards        Pages: 121
    This is a professional and depth research report on Global and China Nalbuphine HCL industry. The report firstly introduced Nalbuphine HCL basic information included Nalbuphine HCL definition classification application industry chain structure industry overview; international market analysis, China domestic market analysis, Macroeconomic environment and economic situation analysis and influence, Nalbuphine HCL industry policy and plan, Nalbuphine HCL product specification, manufacturing process,......
  • 2014 Deep Research Report on Global and China Naltrexone HCL Industry
    Published: 28-Oct-2014        Price: US $2200 Onwards        Pages: 138
    This is a professional and depth research report on Global Naltrexone HCL industry. The report firstly introduced Naltrexone HCL basic information included Naltrexone HCL definition classification application industry chain structure industry overview; international market analysis, China domestic market analysis. Global Regional (such as US Europe Asia China Japan etc regions) Global Leading Suppliers, different type products, different applications etc Naltrexone HCL production and market shar......
  • EpiCast Report: Irritable Bowel Syndrome – Epidemiology Forecast to 2023
    Published: 27-Oct-2014        Price: US $3995 Onwards        Pages: 49
    Irritable Bowel Syndrome (IBS) is a chronic, relapsing gastrointestinal disorder that is characterized by abdominal discomfort or pain, bloating, and changes in bowel habit. Due to the lack of a demonstrable structural abnormality to explain these symptoms, IBS is classified as a functional gastrointestinal disorder. IBS is one of the most common gastrointestinal disorders; moreover, it has a significant negative impact on a patient's quality of life and social functioning. That said, IBS is ......
  • EpiCast Report: Cushing’s Syndrome – Epidemiology Forecast to 2023
    Published: 27-Oct-2014        Price: US $3995 Onwards        Pages: 58
    Cushing's syndrome (CS) is a rare disorder caused by prolonged exposure to excess amounts of circulating free glucocorticoids, such as cortisol. Cortisol is a hormone produced by the adrenal glands that has many functions in the body, such as anti-inflammatory action, antiallergic action, antianabolic action, and amino acid catabolic action. CS is associated with increased mortality caused by complications due to excess cortisol. GlobalData epidemiologists forecast an increase in the diagnose......
  • PharmaLeaders: Global Pharmaceutical Market Benchmark Report – Retrospective and Forward-Looking Analysis of the Leading Pharmaceutical Companies
    Published: 27-Oct-2014        Price: US $3995 Onwards        Pages: 376
    The Global Pharmaceutical Market Benchmark Report applies GlobalData's proprietary ranking methodology to compare the competitive positions of 30 leading drug companies on 25 financial metrics. These companies are analyzed based on financial performance, cost-containment, capital structure, and firm utilization to illustrate the different strategies these companies are using to increase value for their shareholders and create a competitive advantage. Throughout the report, GlobalData's Industry ......
  • Enterocolitis – Pipeline Review, H2 2014
    Published: 25-Oct-2014        Price: US $2000 Onwards        Pages: 39
    Enterocolitis - Pipeline Review, H2 2014 Summary Global Markets Direct's, ‘Enterocolitis - Pipeline Review, H2 2014', provides an overview of the Enterocolitis's therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Enterocolitis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news ......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs